Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis

Platelets

Volumn 22, Issue 2, 2011, Pages 157-159

  Richard, Sebastien ^a   Perrin, Julien ^b   Lavandier, Karine ^c   Lacour, Jean Christophe ^a   Ducrocq, Xavier ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b CHU NANCY BRABOIS   (France)

^c Unité Neuro Vasculaire   (France)

Author keywords

Cerebral venous thrombosis; essential thrombocythemia; heparin induced thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; DANAPAROID; HEPARIN; HYDROXYUREA; IMMUNOGLOBULIN G; JANUS KINASE 2; THROMBOCYTE FACTOR 4; WARFARIN;

ADULT; APHASIA; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE REPORT; CEREBRAL VENOUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DECOMPRESSIVE CRANIECTOMY; DEEP VEIN THROMBOSIS; DELAYED DIAGNOSIS; DISEASE DURATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTUBATION; FEMALE; HEADACHE; HEMATOMA; HEMIPARESIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTRACRANIAL HYPERTENSION; LATERAL SINUS THROMBOSIS; LUNG EMBOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OXYGEN SATURATION; PRIORITY JOURNAL; REMISSION; RETINA ISCHEMIA; TEMPORAL LOBE; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VOMITING;

ANTICOAGULANTS; CEREBRAL VEINS; CHONDROITIN SULFATES; DECOMPRESSIVE CRANIECTOMY; DERMATAN SULFATE; FEMALE; HEPARIN; HEPARITIN SULFATE; HUMANS; INTRACRANIAL HYPERTENSION; MIDDLE AGED; PLATELET COUNT; THROMBOCYTHEMIA, ESSENTIAL; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 79751511864     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.527399     Document Type: Article

References (6)

1. Godeneche G, Gaillard N, Roy L, Mania A, Tondeur S, Chomel JC, Lavabre T, Arquizan C, Neau JP. JAK2 V617F mutation associated with cerebral venous thrombosis: A report of five cases. Cerebrovasc Dis 2010;29:206-209.
2. Arellano-Rodrigo E, Alvarez-Larrán A, Reverter JC, Colomer D, Villamor N, Bellosillo B, Cervantes F. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence and JAK2 V617F allele burden. Am J Hematol 2009;84:102-108.
3. Einhäupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P. Heparin treatment in sinus venous thrombosis. Lancet 1991;7:597-600.
4. Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update. Thromb Res 2006;118:165-176. (Pubitemid 43816669)
5. Houston DS. Heparin-induced thrombocytopenia without thrombocytopenia in a patient with essential thrombocythemia. Am J Hematol 2000;65:331-332.
6. Spectre G, Kalish Y, Schliamser L, Varon D. Heparin-induced thrombocytopenia in myeloproliferative disorders: A rare or under-diagnosed complication? Am J Hematol 2008;83: 420-423. (Pubitemid 351614759)